ATLAS / Macro Radar / Reporting / QNCX

Quince Therapeutics, Inc. (QNCX) reporting calendar

Quince Therapeutics, Inc. files periodic reports with the SEC as QNCX on Nasdaq. Atlas tracks 29 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
14 Jul 2026 – 10 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
29

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open QNCX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-217098
10-K31 Dec 202510 Apr 2026100 days0001193125-26-151364
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277529
10-Q30 Jun 202511 Aug 202542 days0000950170-25-106535
10-Q31 Mar 202513 May 202543 days0001662774-25-000032
10-K31 Dec 202424 Mar 202583 days0001662774-25-000012
10-Q30 Sep 202413 Nov 202444 days0001662774-24-000011
10-Q30 Jun 202413 Aug 202444 days0001662774-24-000005
10-Q31 Mar 202413 May 202443 days0000950170-24-058201
10-K31 Dec 20231 Apr 202492 days0000950170-24-039440
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063716
10-Q30 Jun 20233 Aug 202334 days0000950170-23-038042
10-Q31 Mar 202315 May 202345 days0000950170-23-022241
10-K31 Dec 202215 Mar 202374 days0000950170-23-008148
10-Q30 Sep 20229 Nov 202240 days0000950170-22-023877
10-Q30 Jun 20229 Aug 202240 days0000950170-22-016102
10-Q31 Mar 202210 May 202240 days0000950170-22-009040
10-K31 Dec 20211 Mar 202260 days0000950170-22-002571
10-Q30 Sep 202129 Oct 202129 days0000950170-21-002495
10-Q30 Jun 20216 Aug 202137 days0000950170-21-001015
10-Q31 Mar 20216 May 202136 days0001564590-21-025001
10-K31 Dec 20201 Mar 202160 days0001564590-21-009867
10-Q30 Sep 202012 Nov 202043 days0001564590-20-053571
10-Q30 Jun 202014 Aug 202045 days0001564590-20-040300
10-Q31 Mar 202012 May 202042 days0001564590-20-024670
10-K31 Dec 201916 Mar 202076 days0001564590-20-011165
10-Q30 Sep 201912 Nov 201943 days0001564590-19-042988
10-Q30 Jun 20199 Aug 201940 days0001564590-19-031260
10-Q31 Mar 201912 Jun 201973 days0001564590-19-022340

Source: SEC EDGAR company submissions for CIK 0001662774. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.